Background Image
Table of Contents Table of Contents
Previous Page  238 / 658 Next Page
Information
Show Menu
Previous Page 238 / 658 Next Page
Page Background

Compound

Precursor

Ion

m/z

Quantifier

Ion

m/z

Qualifier Ion

m/z

Morphine

286.1

152.1

185.1

Morphine-

d

3

289.1

152.1

185.1

Oxymorphone

302.1

227.1

198.1

Oxymorphone-

d

3

305.1

230.1

201.1

Hydromorphone

286.1

185.0

157.1

Hydromorphone-

d

6

292.1

185.1

157.1

Codeine

300.2

152.1

165.1

Codeine-

d

3

303.1

152.1

215.1

Oxycodone

316.2

241.1

256.1

Oxycodone-

d

3

319.2

244.1

259.1

Hydrocodone

300.1

199.1

171.1

Hydrocodone-

d

3

303.1

199.1

171.1

Table 1. SRM transitions for opiates method

Compound

Precursor

Ion

m/z

Quantifier

Ion

m/z

Qualifier

Ion

m/z

7-Aminoclonazepam

286.1

222.1

250.1

7-Aminoclonazepam-

d

4

290.1

226.1

254.1

7-Aminonitrazepam

252.1

121.1

224.1

7-Aminoflunitrazepam

284.1

135.1

227.1

7-Aminoflunitrazepam-

d

7

291.2

138.2

230.1

α

-Hydroxytriazolam

359.0

331.0

239.0

Lorazepam

321.0

275.0

229.0

α

-Hydroxyalprazolam

325.0

297.1

229.0

α

-Hydroxyalprazolam-

d

5

330.1

302.1

216.1

Oxazepam

287.1

241.1

221.1

Oxazepam-

d

5

292.1

246.1

104.1

2-Hydroxyethylflurazepam 333.1

109.1

109.1

2-Hydroxyethylflurazepam-

d

4

337.1

215.1

113.1

Desalkyflurazepam

289.0

140.0

226.1

Desalkyflurazepam-

d

4

293.1

140.0

230.1

Temazepam

301.1

255.1

177.0

Temazepam-

d

5

306.1

260.1

177.0

Nordiazepam

271.1

140.1

208.1

Nordiazepam-

d

5

276.1

213.1

140.0

Alprazolam

309.1

281.1

205.1

Alprazolam-

d

5

314.1

286.1

210.1

Diazepam

285.1

193.1

154.0

Diazepam-

d

5

290.1

198.1

154.1

Midazolam

326.1

291.1

249.1

Midazolam-

d

4

330.1

295.1

253.1

Table 2. SRM transitions for benzodiazepines method

2

Experimental

Sample Preparation

Tables 1 and 2 contain the lists of opiates and

benzodiazepines analyzed. Sample preparation consisted

of glucuronide hydrolysis followed by dilution. For each

sample, a 200 µL aliquot of urine was spiked with 10 µL

of internal standards solution and 100 µL of

b

-glucuronidaze enzyme in an ammonium acetate buffer

(pH = 5.0). The samples were incubated at 60 °C for

2 hours. A 200 µL aliquot of methanol was added to each

sample to stop enzymatic reaction. Samples were cooled,

centrifuged, and diluted 20 times with deionized water.

Then, 20 µL of sample was injected into the liquid

chromatograph-mass spectrometer (LC-MS) system.

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.0

11.0

12.0

13.0

Prelude SPLC Multiplexing - Same Method on Both Channels

Injection 1

Injection 2

Channel 1

Injection 3

6 Opiates

(10 ng/mL each)

6 Opiates

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.0

11.0

12.0

13.0

Injection 1

Injection 2

Channel 2

Acquisition of relevent MS data

6 Opiates

6 Opiates

Figure 3. Analysis of six opiates (10 ng/mL) using both channels in multiplexed mode